159 related articles for article (PubMed ID: 23198531)
1. [Relation between cardio-ankle vascular index (Cavi) and preheparin serum lipoprotein lipase mass--effect of age adjustment].
Moteki M; Murano T; Kurosu T; Kataoka M; Nakano M; Hiruta N; Shirai K
Rinsho Byori; 2012 Aug; 60(8):734-9. PubMed ID: 23198531
[TBL] [Abstract][Full Text] [Related]
2. Relationship between Lipoprotein Lipase Derived from Subcutaneous Adipose Tissue and Cardio-Ankle Vascular Index in Japanese Patients with Severe Obesity.
Saiki A; Takahashi Y; Nakamura S; Yamaoka S; Abe K; Tanaka S; Watanabe Y; Yamaguchi T; Nagayama D; Ohira M; Oshiro T; Tatsuno I; Shirai K
Obes Facts; 2024; 17(3):255-263. PubMed ID: 38342095
[TBL] [Abstract][Full Text] [Related]
3. Association between urinary 8-hydroxydeoxyguanosine, an indicator of oxidative stress, and the cardio-ankle vascular index in hypertensive patients.
Masugata H; Senda S; Murao K; Inukai M; Himoto T; Hosomi N; Okada H; Goda F
J Atheroscler Thromb; 2012; 19(8):747-55. PubMed ID: 22576471
[TBL] [Abstract][Full Text] [Related]
4. Sarpogrelate hydrochloride decreases cardio-ankle vascular index accompanied by increased serum lipoprotein lipase mass in type 2 diabetic patients.
Nagayama D; Ohira M; Saiki A; Shirai K; Tatsuno I
Int Heart J; 2014; 55(4):337-41. PubMed ID: 24898600
[TBL] [Abstract][Full Text] [Related]
5. [Cardio-ankle vascular index (CAVI) and cardiovascular disease].
Takata M; Shimakura A
Rinsho Byori; 2013 Oct; 61(10):924-33. PubMed ID: 24371997
[TBL] [Abstract][Full Text] [Related]
6. Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome.
Saiki A; Oyama T; Endo K; Ebisuno M; Ohira M; Koide N; Murano T; Miyashita Y; Shirai K
Diabetes Res Clin Pract; 2007 Apr; 76(1):93-101. PubMed ID: 16956692
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the cardio-ankle vascular index, a new indicator of arterial stiffness independent of blood pressure, in obesity and metabolic syndrome.
Satoh N; Shimatsu A; Kato Y; Araki R; Koyama K; Okajima T; Tanabe M; Ooishi M; Kotani K; Ogawa Y
Hypertens Res; 2008 Oct; 31(10):1921-30. PubMed ID: 19015600
[TBL] [Abstract][Full Text] [Related]
8. The angiotensin II receptor antagonist valsartan enhances lipoprotein lipase mass in preheparin serum in type 2 diabetes with hypertension.
Saiki A; Ohira M; Endo K; Koide N; Oyama T; Murano T; Miyashita Y; Shirai K
Diabetes Res Clin Pract; 2006 Dec; 74(3):242-8. PubMed ID: 16713009
[TBL] [Abstract][Full Text] [Related]
9. Association between arterial stiffness and pulmonary function in hypertensive patients.
Masugata H; Senda S; Okada H; Murao K; Inukai M; Himoto T; Hosomi N; Murakami K; Noma T; Kohno M; Goda F
Hypertens Res; 2012 Apr; 35(4):388-92. PubMed ID: 22113357
[TBL] [Abstract][Full Text] [Related]
10. Relationship between preheparin lipoprotein lipase mass concentration in serum and bare metal stent restenosis.
Hitsumoto T; Takahashi M; Iizuka T; Shirai K
J Cardiol; 2006 Aug; 48(2):65-73. PubMed ID: 16948449
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of blood pressure control using a new arterial stiffness parameter, cardio-ankle vascular index (CAVI).
Shirai K; Utino J; Saiki A; Endo K; Ohira M; Nagayama D; Tatsuno I; Shimizu K; Takahashi M; Takahara A
Curr Hypertens Rev; 2013 Feb; 9(1):66-75. PubMed ID: 23807874
[TBL] [Abstract][Full Text] [Related]
12. Preheparin lipoprotein lipase mass is a practical marker of insulin resistance in ambulatory type 2 diabetic patients treated with oral hypoglycemic agents.
Hanyu O; Miida T; Kosuge K; Ito T; Soda S; Hirayama S; Wardaningsih E; Fueki Y; Obayashi K; Aizawa Y
Clin Chim Acta; 2007 Sep; 384(1-2):118-23. PubMed ID: 17651713
[TBL] [Abstract][Full Text] [Related]
13. The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients.
Kobayashi J; Nakajima K; Nohara A; Kawashiri M; Yagi K; Inazu A; Koizumi J; Yamagishi M; Mabuchi H
Horm Metab Res; 2007 Aug; 39(8):612-6. PubMed ID: 17712727
[TBL] [Abstract][Full Text] [Related]
14. Comparison of arteriosclerotic indicators in patients with ischemic stroke: ankle-brachial index, brachial-ankle pulse wave velocity and cardio-ankle vascular index.
Saji N; Kimura K; Yagita Y; Kawarai T; Shimizu H; Kita Y
Hypertens Res; 2015 May; 38(5):323-8. PubMed ID: 25716647
[TBL] [Abstract][Full Text] [Related]
15. Cardio-ankle vascular index reflects coronary atherosclerosis in patients with abnormal glucose metabolism: assessment with 256 slice multi-detector computed tomography.
Park HE; Choi SY; Kim MK; Oh BH
J Cardiol; 2012 Nov; 60(5):372-6. PubMed ID: 22890071
[TBL] [Abstract][Full Text] [Related]
16. Arterial stiffness evaluation by cardio-ankle vascular index in hypertension and diabetes mellitus subjects.
Wang H; Liu J; Zhao H; Fu X; Shang G; Zhou Y; Yu X; Zhao X; Wang G; Shi H
J Am Soc Hypertens; 2013; 7(6):426-31. PubMed ID: 23871571
[TBL] [Abstract][Full Text] [Related]
17. Silent brain infarct is independently associated with arterial stiffness indicated by cardio-ankle vascular index (CAVI).
Saji N; Kimura K; Shimizu H; Kita Y
Hypertens Res; 2012 Jul; 35(7):756-60. PubMed ID: 22378472
[TBL] [Abstract][Full Text] [Related]
18. Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives.
Shirai K; Hiruta N; Song M; Kurosu T; Suzuki J; Tomaru T; Miyashita Y; Saiki A; Takahashi M; Suzuki K; Takata M
J Atheroscler Thromb; 2011; 18(11):924-38. PubMed ID: 21628839
[TBL] [Abstract][Full Text] [Related]
19. Improved assessment of arterial stiffness using corrected cardio-ankle vascular index (CAVI
Mestanik M; Jurko A; Spronck B; Avolio AP; Butlin M; Jurko T; Visnovcova Z; Mestanikova A; Langer P; Tonhajzerova I
Scand J Clin Lab Invest; 2017 Dec; 77(8):665-672. PubMed ID: 29103321
[TBL] [Abstract][Full Text] [Related]
20. The Role of a Novel Arterial Stiffness Parameter, Cardio-Ankle Vascular Index (CAVI), as a Surrogate Marker for Cardiovascular Diseases.
Saiki A; Sato Y; Watanabe R; Watanabe Y; Imamura H; Yamaguchi T; Ban N; Kawana H; Nagumo A; Nagayama D; Ohira M; Endo K; Tatsuno I
J Atheroscler Thromb; 2016; 23(2):155-68. PubMed ID: 26607350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
